Seite - (000156) - in Advances in Neuroimmunology

BrainSci. 2017,7, 11 165. Posti, J.P.; Takala,R.S.;Runtti,H.;Newcombe,V.F.;Outtrim, J.;Katila,A.J.; Frantzen, J.;Ala-Seppala,H.; Coles, J.P.;Hossain,M.I.;etal. Thelevelsofglialfibrillaryacidicproteinandubiquitinc-terminalhydrolase-l1 during the first week after a traumatic brain injury: Correlations with clinical and imaging findings. Neurosurgery2016,79, 456–464. [PubMed] 166. Mondello, S.; Kobeissy, F.; Vestri,A.;Hayes,R.L.; Kochanek, P.M.; Berger,R.P. Serumconcentrations of ubiquitin c-terminalhydrolase-l1 andglialfibrillaryacidicproteinafterpediatric traumaticbrain injury. Sci.Rep. 2016,6, 28203. [CrossRef] [PubMed] 167. Yan,E.B.; Satgunaseelan,L.;Paul,E.;Bye,N.;Nguyen,P.;Agyapomaa,D.;Kossmann,T.;Rosenfeld, J.V.; Morganti-Kossmann,M.C.Post-traumatichypoxiaisassociatedwithprolongedcerebralcytokineproduction, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury. J.Neurotrauma2014,31, 618–629. [CrossRef] [PubMed] 168. Ottens,A.K.;Golden,E.C.;Bustamante,L.;Hayes,R.L.;Denslow,N.D.;Wang,K.K.Proteolysisofmultiple myelinbasicprotein isoformsafterneurotrauma:Characterizationbymassspectrometry. J.Neurochem. 2008, 104, 1401–1414. [CrossRef] [PubMed] 169. Cox,A.L.;Coles,A.J.;Nortje, J.;Bradley,P.G.;Chatfield,D.A.;Thompson,S.J.;Menon,D.K.Aninvestigation ofauto-reactivityafterheadinjury. J.Neuroimmunol. 2006,174, 180–186. [CrossRef] [PubMed] 170. Kalia,V.;Sarkar,S.;Ahmed,R.Cd8t-cellmemorydifferentiationduringacuteandchronicviral infections. Adv. Exp.Med. Biol. 2010,684, 79–95. [PubMed] 171. Goverman, J.Autoimmune t cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9, 393–407. [CrossRef] [PubMed] 172. McFarland,H.F.;Martin,R.Multiplesclerosis:Acomplicatedpictureofautoimmunity.Nat. Immunol. 2007, 8, 913–919. [CrossRef] [PubMed] 173. Lucchinetti,C.;Bruck,W.;Parisi, J.; Scheithauer,B.;Rodriguez,M.;Lassmann,H.Heterogeneityofmultiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47, 707–717. [CrossRef] 174. Ransohoff,R.M.;Kivisakk,P.;Kidd,G.Threeormoreroutes for leukocytemigration into thecentralnervous system.Nat. Rev. Immunol. 2003,3, 569–581. [CrossRef] [PubMed] 175. Ginhoux,F.;Lim,S.;Hoeffel,G.;Low,D.;Huber,T.Originanddifferentiationofmicroglia.Front.CellNeurosci. 2013,7, 45. [CrossRef] [PubMed] 176. Harry,G.J.Microglia duringdevelopment and aging. Pharmacol. Ther. 2013, 139, 313–326. [CrossRef] [PubMed] 177. Papa, L.; Brophy, G.M.; Welch, R.D.; Lewis, L.M.; Braga, C.F.; Tan, C.N.; Ameli, N.J.; Lopez, M.A.; Haeussler,C.A.;MendezGiordano,D.I.; etal. Timecourseanddiagnosticaccuracyofglialandneuronal bloodbiomarkersgfapanduch-l1 ina largecohortof traumapatientswithandwithoutmild traumatic brain injury. JAMANeurol. 2016,73, 551–560. [CrossRef] [PubMed] 178. Zoltewicz, J.S.; Scharf,D.;Yang,B.;Chawla,A.;Newsom,K.J.;Fang,L.Characterizationofantibodies that detecthumangfapafter traumaticbrain injury.Biomark. Insights2012,7, 71–79. [CrossRef] [PubMed] 179. Bogoslovsky, T.; Wilson, D.; Chen, Y.; Hanlon, D.; Gill, J.; Jeromin, A.; Song, L.; Moore, C.; Gong, Y.; Kenney,K.; et al. Increasesofplasma levelsofglialfibrillaryacidicprotein, tau, andamyloidbetaup to 90daysafter traumaticbrain injury. J.Neurotrauma2017,34, 66–73. [CrossRef] [PubMed] 180. Su,E.;Bell,M.J.;Kochanek,P.M.;Wisniewski,S.R.;Bayir,H.;Clark,R.S.;Adelson,P.D.;Tyler-Kabara,E.C.; Janesko-Feldman,K.L.;Berger,R.P. Increasedcsfconcentrationsofmyelinbasicproteinafter tbi in infants andchildren: Absenceof significanteffectof therapeutichypothermia.Neurocrit. Care2012,17, 401–407. [CrossRef] [PubMed] 181. Raper,D.;Louveau,A.;Kipnis, J.Howdomeningeal lymphaticvesselsdrain thecns?TrendsNeurosci. 2016, 39, 581–586. [CrossRef] [PubMed] 182. Louveau,A.;DaMesquita,S.;Kipnis, J.Lymphatics inneurologicaldisorders:Aneuro-lympho-vascular componentofmultiplesclerosisandalzheimer’sdisease?Neuron2016,91, 957–973. [CrossRef] [PubMed] 183. Brait,V.H.;Arumugam,T.V.;Drummond,G.R.; Sobey,C.G. Importanceof t lymphocytes inbrain injury, immunodeficiency, and recovery after cerebral ischemia. J. Cereb. Blood FlowMetab. 2012, 32, 598–611. [CrossRef] [PubMed] 146